Navigation Links
ePharmaSolutions Launches New Version of Electronic Monitor Visit Report Application With Industry-Leading Online and Offline Capabilities
Date:6/17/2010

CONSHOHOCKEN, Pa., June 17 /PRNewswire/ -- ePharmaSolutions, a leading provider of clinical research technologies and niche clinical services, launches version 3.0 of its eMVR (Electronic Monitor Visit Report) application with new features to support online and offline completion of monitoring reports for traveling clinical research associates and integrations with leading CTMS systems.

"Our latest release provides study monitors with the option of completing monitor reports online or offline, more robust reporting, and CTMS integration points," stated Steven Beales, ePharmaSolutions' Vice President of Information Technology.

ePharmaSolutions' Clinical Trial Portal (CTP) is used by more than 200,000 clinical researchers in 107 countries to help accelerate and improve site feasibility, study training, site activation and patient enrollment.  CTP version 4.0 contains new functionality for sponsors that includes eMVR (Electronic Monitor Visit Report) to support the authoring, completion and submission of online and offline monitor trip reports with electronic signature.  The new version of eMVR allows study monitors to complete their site visit reports online or offline in Microsoft Word.  The offline reports can be submitted back to the eMVR and the data is pulled from the Word template back into the system.  The eMVR auto-populates visit reports, confirmation and follow-up letters, and carries all follow-up data from one report to either follow-up letters or future visit reports.  The eMVR includes a robust tracking and reporting system for study managers and integrates with leading CTMS systems.

"Our clients have been asking for an offline monitor visit report completion feature for some time and the market has not been responding in a timely enough manner," stated Lance Converse, ePharmaSolutions' Founder and CEO.  "Our development team did an excellent job building out these features into this release to support the global needs of our biopharmaceutical and CRO clients," Converse added.

ePharmaSolutions' Clinical Trial Portal (CTP) provides biopharmaceutical companies and CROs with a fully validated solution to help accelerate and improve study start-up and site management through a variety of "Site Friendly" components that include: site feasibility application (SFA), secure document exchange (SDE), safety letter distribution (SLD), electronic monitor visit reporting (eMVR), learning management system (LMS), and the patient recruitment manager (PRM).  Future plans in 2010 include the inclusion of a grant payment tracking application for sponsors/sites and integration of 80 million EMR records into its investigator database for improved decision support during the site selection process.

About ePharmaSolutions, Inc.

ePharmaSolutions is a leading provider of technology-based clinical services that help improve the way sites are selected, trained, activated and supported to start clinical trials and meet enrollment goals. ePharmaSolutions has activated and trained more than 185,000 clinical researchers in 107 countries for the top 20 pharmaceutical companies in the world and is headquartered in Philadelphia, Pennsylvania. For more information call 610-832-9915 or visit www.epharmasolutions.com.


'/>"/>
SOURCE ePharmaSolutions
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ePharmaSolutions Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award
2. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
3. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
4. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
5. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
6. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
7. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
8. Premier Micronutrient Launches Supplement for Hearing Health
9. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
10. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
11. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... technology to revolutionize the emergency ambulance transport experience for the millions of people ... how Uber has disrupted the taxi industry through the use of technology. Now, ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A ... 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the ... history as home to some of the world’s leading providers of cereal and other ...
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
Breaking Medicine News(10 mins):